461 Mrv1909 05171921052D 17 18 0 0 0 0 999 V2000 2.3621 -1.2428 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.1318 1.2515 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.9885 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.7029 0.4265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5596 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5596 -0.8104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2742 0.4265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.4170 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9885 -0.8104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2742 -1.2229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8222 0.4551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8222 -1.2515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0748 -0.8276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0748 0.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.1318 0.4265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.8459 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.4170 -0.8102 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 13 1 0 0 0 0 2 15 1 0 0 0 0 3 4 1 0 0 0 0 3 7 2 0 0 0 0 3 9 1 0 0 0 0 4 8 1 0 0 0 0 5 6 2 0 0 0 0 5 7 1 0 0 0 0 5 11 1 0 0 0 0 6 10 1 0 0 0 0 6 12 1 0 0 0 0 8 15 1 0 0 0 0 9 10 2 0 0 0 0 11 14 2 0 0 0 0 12 13 2 0 0 0 0 13 14 1 0 0 0 0 15 16 1 0 0 0 0 8 17 1 0 0 0 0 M END > DBMET02531 > drugbank > CC(O)C(O)CC1=CC2=C(C=C1)C=C(O)C=C2 > InChI=1S/C14H16O3/c1-9(15)14(17)7-10-2-3-12-8-13(16)5-4-11(12)6-10/h2-6,8-9,14-17H,7H2,1H3 > VURKJRPIIZIBLT-UHFFFAOYSA-N > C14H16O3 > 232.279 > 232.109944375 > 3 > 33 > 25.528802473076667 > 1 > 3 > 0 > 1 > 1-(6-hydroxynaphthalen-2-yl)butane-2,3-diol > 1.64 > 1.9667087713333329 > -2.93 > 0 > 2 > 0 > 13.956731481265152 > 9.787279676687422 > -3.015222307454822 > 60.69 > 66.44130000000001 > 3 > 1 > 2.72e-01 g/l > (1S,2R,3S,4S)-2,3,4,5-tetrahydroxy-6-({[2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-yl]oxy}methyl)cyclohexane-1-carboxylic acid > 0 > DBMET02531 > reduced O-desmethyl-3-hydroxy-nabumetone $$$$